Sign in
Taking people in United StatesNo phase

Following people for a year after nerve freezing treatment for long-lasting pain

Follows adults with chronic pain after cryoneurolysis, tracking outcomes through 12 months.

Key facts

Who runs it
Yale University
Where
Old Saybrook, United StatesSee the site
Trial code
Registry title
Prospective Case Series Evaluating 6-Month and 12-Month Outcomes After Cryoneurolysis for Chronic Pain
Status
Recruiting
People taking part
80 people, planned
Started
20 Jun 2026
Expected to end
Jul 2028
Type of study
Observational
Record updated
21 August 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with chronic pain who are already planned to have cryoneurolysis (freezing a nerve to block pain) as routine care at Yale. It follows how they do for 12 months.

Age
18 Years and older
Sex
All sexes can join.
Disease stage
Chronic pain, generally lasting at least 3-6 months, in a body area the treating doctor judges can be treated with cryoneurolysis.
Earlier treatment
A cryoneurolysis procedure must already be planned as part of standard care.

Main reasons for not taking part

  • Cryoneurolysis done in another research trial that does not allow data sharing
  • Active infection or another medical reason the procedure cannot be done
  • Expected to live less than 12 months, in the doctor's judgment
  • Conditions that would get in the way of follow-up, such as severe psychiatric instability or active substance use
  • Not able to give written consent or complete the questionnaires

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Diagnosis of chronic pain (generally pain duration of at least 3-6 months) localized to an anatomical region appropriate for cryoneurolysis as determined by the treating physician
  • Planned cryoneurolysis procedure as part of standard clinical care
  • Ability to provide written informed consent
  • Ability and willingness to complete baseline and follow-up questionnaires

Who cannot take part

  • Active infection or other clinical contraindication to the procedure as determined by the treating clinician
  • Any condition that, in the investigator's opinion, would interfere with study participation or completion of follow-up, such as severe psychiatric instability or active substance use that precludes reliable follow-up
  • Cryoneurolysis performed as part of a separate investigational trial in which data sharing is not permitted
  • Life expectancy of less than 12 months in the judgment of the treating clinician

Where in United States

  • Yale New Haven Health Old Saybrook Medical CenterOld Saybrook, United StatesContact: Charles A Odonkor, MDTaking people

About the trial

What the trial wants to find out

To prospectively describe patient-centered and health utilization outcomes through 12 months after cryoneurolysis performed as routine clinical care for chronic pain at Yale.

The group in the trial

  • Participants undergoing cryoneurolysis

    Participants undergoing cryoneurolysis for chronic pain as part of standard clinical care.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Prospective Case Series Evaluating 6-Month and 12-Month Outcomes After Cryoneurolysis for Chronic Pain
Plain-language title
Following people for a year after nerve freezing treatment for long-lasting painGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
21 August 2026